Ligand ID: ILE


Drugbank ID:
DB00167
(L-Isoleucine)


Indication:
The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.

Get human targets for ILE in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'ILE' AND SARS-COV-2 / COVID-19 STRUCTURES

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.06A16.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 6
THR A 175
VAL A  86
VAL A 148
HIS A 163
1.79A16.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 6
THR A 175
VAL A  86
VAL A 148
HIS A 163
1.78A16.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6lze VIRAL PROTEASE
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.06A20.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6lze VIRAL PROTEASE
(SARS-CoV-2)		4 / 6
THR A 175
VAL A  86
VAL A 148
HIS A 163
1.78A20.14
None
None
None
ELL  D   3 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.05A20.07
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 6
ILE D 213
ALA D 255
THR D 257
VAL D 297
1.11A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.09A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 6
ILE C 213
ALA C 255
THR C 257
VAL C 297
1.09A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 6
ILE B 213
ALA B 255
THR B 257
VAL B 297
1.10A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 6
ALA A  94
THR A  93
VAL A  91
VAL A  73
1.66A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m2q 3CL PROTEASE
(SARS-CoV-2)		4 / 6
ALA A  94
THR A  93
VAL A  91
VAL A  73
1.49A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m2q 3CL PROTEASE
(SARS-CoV-2)		4 / 6
THR A 175
VAL A  86
VAL A 148
HIS A 163
1.80A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m2q 3CL PROTEASE
(SARS-CoV-2)		4 / 6
THR A 175
VAL A  86
VAL A 148
HIS A 163
1.77A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m2q 3CL PROTEASE
(SARS-CoV-2)		4 / 6
ALA A  94
THR A  93
VAL A  91
VAL A  73
1.40A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m2q 3CL PROTEASE
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.07A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 585
THR A 586
VAL A 587
VAL A 605
1.73A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 585
THR A 586
VAL A 587
VAL A 605
1.75A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
THR A 344
VAL A 359
VAL A 535
HIS A 355
1.66A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
THR A 344
VAL A 359
VAL A 535
HIS A 355
1.54A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.29A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ILE A 696
ALA A 702
VAL A 700
VAL A 764
1.50A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 585
THR A 586
VAL A 588
VAL A 605
1.59A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 878
THR A 870
TYR A 867
VAL A 820
1.77A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ILE A 715
ALA A  46
THR A 710
VAL A  42
1.60A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.30A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 585
THR A 586
VAL A 588
VAL A 605
1.62A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 878
TYR A 884
VAL A 435
HIS A 872
1.63A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
THR A 344
VAL A 359
VAL A 535
HIS A 355
1.67A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ILE A 757
THR A 586
VAL A 588
VAL A 763
1.50A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.33A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 878
THR A 870
TYR A 867
VAL A 820
1.77A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 878
TYR A 884
VAL A 435
HIS A 872
1.56A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 702
THR A 701
VAL A 704
VAL A 476
1.27A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.30A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ILE A 757
THR A 586
VAL A 588
VAL A 764
1.49A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP12
(SARS-CoV-2)		4 / 6
ALA A 878
TYR A 884
VAL A 435
HIS A 872
1.61A19.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6m71 NSP8
(SARS-CoV-2)		4 / 6
ILE B 185
ALA B 188
THR B 187
VAL B 130
1.52A15.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
ALA B  89
VAL B  30
VAL B 121
HIS B  91
1.78A
None
None
None
NHE  B 203 ( 3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
ILE A  23
ALA A  50
VAL A  36
HIS A  45
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
ILE B  23
ALA B  50
VAL B  36
HIS B  45
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.43A
None
None
None
NHE  A 202 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
ALA B  89
VAL B  30
VAL B 121
HIS B  91
1.80A
None
None
None
NHE  B 203 ( 3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.48A
None
None
None
NHE  B 203 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.49A
None
None
None
NHE  A 202 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.55A
None
None
None
NHE  B 203 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.49A
None
None
None
NHE  A 202 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6vxs NSP3
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.55A
None
None
None
NHE  B 203 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w41 SPIKE PROTEIN S1
(SARS-CoV-2)		4 / 6
ILE C 358
ALA C 522
THR C 523
VAL C 362
1.55A14.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w4h NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.43A19.10
None
None
None
SAM  A7102 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.54A
None
None
None
SAM  A7104 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE A6910
ALA A6877
VAL A6902
HIS A6867
1.71A13.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
VAL A6876
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE A6926
ALA A6881
THR A6880
VAL A6882
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
VAL A6876
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE A6838
THR A6846
VAL A6882
VAL A6995
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.44A
None
None
None
SAM  A7104 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.36A
None
None
None
SAM  A7104 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE A6866
ALA A6919
VAL A7086
VAL A6916
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 6
THR A 175
VAL A  86
VAL A 148
HIS A 163
1.78A
None
None
None
X77  A 401 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.10A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.74A13.72
None
AMP  A 201 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ILE B  23
ALA B  50
VAL B  36
HIS B  45
1.63A13.72
None
MES  B 201 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  35
HIS B  94
1.72A13.72
MES  B 201 ( 3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  95
HIS A  45
1.65A
None
AMP  A 201 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  96
HIS A  45
1.62A
None
AMP  A 201 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
THR B 146
VAL B 142
TYR B 113
VAL B  16
1.77A13.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ILE A  23
ALA A  50
VAL A  35
HIS A  45
1.77A13.72
AMP  A 201 ( 4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.74A13.72
None
AMP  A 201 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.79A
None
AMP  A 201 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ILE A  23
ALA A  50
VAL A  36
HIS A  45
1.61A
AMP  A 201 ( 4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  95
HIS B  45
1.63A
MES  B 201 ( 3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ILE B  23
ALA B  50
VAL B  35
HIS B  45
1.79A13.72
None
MES  B 201 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  45
1.69A13.72
None
AMP  A 201 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  35
HIS B  94
1.71A13.72
MES  B 201 ( 3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  95
HIS A  45
1.59A
None
AMP  A 201 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
THR A 146
VAL A 142
TYR A 113
VAL A  16
1.76A13.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  95
HIS B  45
1.68A
MES  B 201 ( 3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  96
HIS B  45
1.67A
MES  B 201 ( 3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  35
HIS B  45
1.70A13.72
MES  B 201 ( 3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w6y NSP3
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  35
HIS B  94
1.76A
MES  B 201 ( 3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
TYR C6845
1.34A14.68
None
None
None
SAM  C7105 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.58A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.63A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
VAL C6876
1.68A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.59A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ILE A6838
THR A6846
VAL A6882
VAL A6995
1.60A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ILE C6838
THR C6846
VAL C6882
VAL C6995
1.57A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.55A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ILE C6866
ALA C6919
THR C6918
VAL A7094
1.50A14.68
None
None
FMT  C7113 ( 4.8A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
VAL A6876
1.68A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.33A14.68
None
None
None
SAM  A7102 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.41A14.68
None
None
None
SAM  A7102 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
TYR C6845
1.52A14.68
None
None
None
SAM  C7105 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ILE C6926
ALA C6881
THR C6880
VAL C6882
1.54A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ILE A6926
ALA A6881
THR A6880
VAL A6882
1.54A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
VAL A6876
1.67A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ILE C6866
ALA C6919
VAL C7086
VAL C6916
1.67A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
VAL C6876
1.67A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.55A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.51A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.51A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ILE A6866
ALA A6919
VAL A7086
VAL A6916
1.65A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
TYR C6845
1.42A14.68
None
None
None
SAM  C7105 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ILE A6866
ALA A6919
THR A6918
VAL C7094
1.60A14.68
None
None
FMT  A7109 ( 4.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.55A14.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w75 NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.51A14.68
None
None
None
SAM  A7102 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR C  34
VAL C  41
TYR C  27
VAL C   7
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR B  34
VAL B  41
TYR B  27
VAL B   7
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR B  54
VAL B   7
VAL B  57
HIS B  17
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR B  54
VAL B   7
VAL B  57
HIS B  17
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR B  34
VAL B  41
TYR B  27
VAL B   7
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR A  34
VAL A  41
TYR A  27
VAL A   7
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
ALA C 261
VAL C 303
VAL C 165
HIS C 275
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR A  34
VAL A  41
TYR A  27
VAL A   7
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
ALA C 261
VAL C 303
VAL C 165
HIS C 275
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
ALA A 261
VAL A 303
VAL A 165
HIS A 275
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
ALA A 261
VAL A 303
VAL A 165
HIS A 275
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
ALA B 261
VAL B 303
VAL B 165
HIS B 275
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR B  34
VAL B  41
TYR B  27
VAL B   7
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
ALA B 261
VAL B 303
VAL B 165
HIS B 275
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
ALA B 261
VAL B 303
VAL B 165
HIS B 275
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR A  34
VAL A  41
TYR A  27
VAL A   7
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR C  34
VAL C  41
TYR C  27
VAL C   7
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
ALA A 261
VAL A 303
VAL A 165
HIS A 275
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
THR C  34
VAL C  41
TYR C  27
VAL C   7
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 6
ALA C 261
VAL C 303
VAL C 165
HIS C 275
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.70A
MES  A 201 ( 3.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
ALA A  89
VAL A  30
VAL A 121
HIS A  91
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.78A
MES  A 201 ( 3.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
ILE A  23
ALA A  50
VAL A  36
HIS A  45
1.62A
None
MES  A 201 ( 3.0A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
ALA A  89
VAL A  30
VAL A 121
HIS A  91
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  95
HIS A  45
1.61A
MES  A 201 ( 3.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.65A
MES  A 201 ( 3.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wcf NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  95
HIS A  45
1.67A
MES  A 201 ( 3.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  95
HIS A  45
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  96
HIS A  45
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
ILE A  23
ALA A  39
VAL A  35
HIS A  94
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
ILE A  23
ALA A  50
VAL A  36
HIS A  45
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  95
HIS A  45
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  96
HIS A  45
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wen NSP3
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wey NSP3
(SARS-CoV-2)		4 / 6
ALA A 254
VAL A 253
VAL A 299
HIS A 249
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wey NSP3
(SARS-CoV-2)		4 / 6
ALA A 254
VAL A 253
VAL A 239
HIS A 298
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wey NSP3
(SARS-CoV-2)		4 / 6
ALA A 254
VAL A 253
VAL A 300
HIS A 249
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wey NSP3
(SARS-CoV-2)		4 / 6
ALA A 254
VAL A 253
VAL A 299
HIS A 249
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wey NSP3
(SARS-CoV-2)		4 / 6
VAL A 351
TYR A 317
VAL A 240
HIS A 323
1.49A15.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wey NSP3
(SARS-CoV-2)		4 / 6
VAL A 351
TYR A 317
VAL A 240
HIS A 323
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wey NSP3
(SARS-CoV-2)		4 / 6
ILE A 227
ALA A 254
VAL A 240
HIS A 249
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wey NSP3
(SARS-CoV-2)		4 / 6
VAL A 351
TYR A 317
VAL A 240
HIS A 323
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wey NSP3
(SARS-CoV-2)		4 / 6
ILE A 227
ALA A 243
VAL A 239
HIS A 298
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wiq NSP8
(SARS-CoV-2)		4 / 6
ALA B 188
THR B 187
VAL B 130
VAL B 160
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
TYR C6845
1.41A
None
None
None
SAH  C7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.40A
None
None
None
SAH  A7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
VAL C6876
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.55A
None
FMT  C7107 (-3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
VAL C6876
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.51A
None
FMT  C7107 (-3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
VAL A6876
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE A6926
ALA A6881
THR A6880
VAL A6882
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE A6838
THR A6846
VAL A6882
VAL A6995
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE A6866
ALA A6919
THR A6918
VAL C7094
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.59A
None
FMT  C7107 (-3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.52A
None
FMT  C7107 (-3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.50A
None
None
None
SAH  A7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
VAL A6876
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE C6838
THR C6846
VAL C6882
VAL C6995
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
TYR C6845
1.51A
None
None
None
SAH  C7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
TYR C6845
1.34A
None
None
None
SAH  C7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE C6926
ALA C6881
THR C6880
VAL C6882
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE C6866
ALA C6919
THR C6918
VAL A7094
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.32A
None
None
None
SAH  A7102 (-4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
VAL C6876
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.41A
None
None
None
SFG  A7103 ( 4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ILE A6926
ALA A6881
THR A6880
VAL A6882
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ILE A6866
ALA A6919
THR A6918
VAL C7094
1.56A
None
None
FMT  A7108 ( 4.8A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
TYR C6845
1.42A
None
None
None
SFG  C7103 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ILE C6838
THR C6846
VAL C6882
VAL C6995
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
VAL A6876
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
TYR C6845
1.51A
None
None
None
SFG  C7103 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ILE C6926
ALA C6881
THR C6880
VAL C6882
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ILE A6838
THR A6846
VAL A6882
VAL A6995
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
VAL C6876
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ILE C6866
ALA C6919
THR C6918
VAL A7094
1.56A
None
None
FMT  C7108 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.51A
None
None
None
SFG  A7103 ( 4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA A6914
THR A6915
VAL A6916
VAL C7087
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.33A
None
None
None
SFG  A7103 ( 4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA C6881
THR C6880
VAL C6882
TYR C6845
1.34A
None
None
None
SFG  C7103 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
VAL A6876
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wkq NSP16
(SARS-CoV-2)		4 / 6
ALA C6914
THR C6915
VAL C6916
VAL A7087
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
ALA A  81
THR A  84
VAL A  67
HIS A  96
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
ILE B  28
THR B  31
VAL B  52
VAL B  25
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
ILE A  28
THR A  31
VAL A  52
VAL A  25
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
ALA B  81
THR B  84
VAL B  67
HIS B  96
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
THR A 341
VAL A 339
VAL A 237
HIS A 235
1.70A
U5P  A 401 ( 4.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
ILE B 144
ALA B  81
VAL B  78
VAL B  67
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
THR B  84
VAL B 102
VAL B 122
HIS B  96
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
THR A  84
VAL A 102
VAL A 122
HIS A  96
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
ALA A  81
THR A  84
VAL A  67
HIS A  96
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
ALA A  82
THR A  84
VAL A 102
VAL A 128
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
ALA B  82
THR B  84
VAL B 102
VAL B 128
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
ILE A 144
ALA A  81
VAL A  78
VAL A  67
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 6
ALA B  81
THR B  84
VAL B  67
HIS B  96
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.07A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 6
THR A 175
VAL A  86
VAL A 148
HIS A 163
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 6
THR A 175
VAL A  86
VAL A 148
HIS A 163
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ALA C  50
VAL C  49
VAL C  96
HIS C  45
1.70A
APR  C 201 (-3.5A)
APR  C 201 (-3.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ALA D  50
VAL D  49
VAL D  35
HIS D  94
1.78A
APR  D 201 ( 3.7A)
APR  D 201 (-3.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL D 147
TYR D 113
VAL D  36
HIS D 119
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ALA D  50
VAL D  49
VAL D  96
HIS D  45
1.69A
APR  D 201 ( 3.7A)
APR  D 201 (-3.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL D 147
TYR D 113
VAL D  36
HIS D 119
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ALA B  89
VAL B  30
VAL B 121
HIS B  91
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ALA B  89
VAL B  30
VAL B 121
HIS B  91
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL D 147
TYR D 113
VAL D  36
HIS D 119
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  96
HIS A  45
1.70A
APR  A 201 (-3.4A)
APR  A 201 (-3.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ALA C  89
VAL C  30
VAL C 121
HIS C  91
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.55A
None
None
None
SAH  A7101 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.37A
None
None
None
SAH  A7101 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
TYR A6845
1.45A
None
None
None
SAH  A7101 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE A6838
THR A6846
VAL A6882
VAL A6995
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
VAL A6876
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ALA A6881
THR A6880
VAL A6882
VAL A6876
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 6
ILE A6926
ALA A6881
THR A6880
VAL A6882
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wqd NSP8
(SARS-CoV-2)		4 / 6
ALA D 188
THR D 187
VAL D 130
VAL D 160
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wqd NSP7
NSP8
(SARS-CoV-2)		4 / 6
ILE A  68
ALA A  65
VAL A  66
VAL B 115
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wqd NSP8
(SARS-CoV-2)		4 / 6
ALA B 188
THR B 187
VAL B 130
VAL B 160
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 6
ALA A  94
THR A  93
VAL A  91
VAL A  73
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.04A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 6
THR A  54
VAL A   7
VAL A  57
HIS A  17
1.57A
None
None
None
CL  A 506 ( 4.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 6
THR A  54
VAL A   7
VAL A  57
HIS A  17
1.63A
None
None
None
CL  A 506 ( 4.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 6
ALA A 261
VAL A 303
VAL A 165
HIS A 275
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 6
THR A  54
VAL A   7
VAL A  57
HIS A  17
1.38A
None
None
None
CL  A 506 ( 4.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 6
THR A  34
VAL A  41
TYR A  27
VAL A   7
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 6
ALA A 261
VAL A 303
VAL A 165
HIS A 275
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 6
THR A  54
VAL A   7
VAL A  57
HIS A  17
1.60A
None
None
None
CL  A 506 ( 4.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6y2e REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ALA A  94
THR A  93
VAL A  91
VAL A  73
1.47A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6y84 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.05A20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.05A16.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
THR A 175
VAL A  86
VAL A 148
HIS A 163
1.80A16.10
None
None
None
DMS  A 405 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
THR A 175
VAL A  86
VAL A 148
HIS A 163
1.78A16.10
None
None
None
DMS  A 405 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 6
ILE A  68
ALA A  65
VAL A  66
VAL B 115
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 6
ILE A 358
ALA A 522
THR A 523
VAL A 362
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 6
ILE E 358
ALA E 522
THR E 523
VAL E 362
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ym0 SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 6
ILE E 358
ALA E 522
THR E 523
VAL E 362
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.04A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 6
ILE E 358
ALA E 522
THR E 523
VAL E 362
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 6
ILE A 358
ALA A 522
THR A 523
VAL A 362
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ALA A  94
THR A  93
VAL A  91
VAL A  73
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.06A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA C  50
VAL C  49
VAL C  96
HIS C  45
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA D  50
VAL D  49
VAL D  35
HIS D  94
1.69A
EDO  D 206 (-3.6A)
EDO  D 209 (-4.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ILE A  23
ALA A  50
VAL A  36
HIS A  45
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  96
HIS B  45
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.51A
None
None
None
EDO  C 207 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  35
HIS B  94
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA C  50
VAL C  49
VAL C  95
HIS C  45
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL E 147
TYR E 113
VAL E  36
HIS E 119
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ILE B  23
ALA B  39
VAL B  35
HIS B  94
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA D  50
VAL D  49
VAL D  35
HIS D  94
1.75A
EDO  D 206 (-3.6A)
EDO  D 209 (-4.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ILE B  23
ALA B  50
VAL B  36
HIS B  45
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA E  50
VAL E  49
VAL E  95
HIS E  45
1.68A
EPE  E 202 (-3.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL E 147
TYR E 113
VAL E  36
HIS E 119
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL E 147
TYR E 113
VAL E  36
HIS E 119
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA D  50
VAL D  49
VAL D  95
HIS D  45
1.70A
EDO  D 206 (-3.6A)
EDO  D 209 (-4.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL D 147
TYR D 113
VAL D  36
HIS D 119
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ILE C  23
ALA C  39
VAL C  35
HIS C  94
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  96
HIS A  45
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.51A
None
None
None
EDO  C 207 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ILE C  23
ALA C  50
VAL C  36
HIS C  45
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  95
HIS B  45
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA C  50
VAL C  49
VAL C  35
HIS C  94
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA C  50
VAL C  49
VAL C  35
HIS C  94
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.43A
None
None
None
EDO  C 207 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL D 147
TYR D 113
VAL D  36
HIS D 119
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL D 147
TYR D 113
VAL D  36
HIS D 119
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA D  50
VAL D  49
VAL D  96
HIS D  45
1.66A
EDO  D 206 (-3.6A)
EDO  D 209 (-4.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA E  50
VAL E  49
VAL E  35
HIS E  94
1.76A
EPE  E 202 (-3.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  95
HIS B  45
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  95
HIS A  45
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ILE E  23
ALA E  39
VAL E  35
HIS E  94
1.63A
EDO  E 205 (-4.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ILE E  23
ALA E  50
VAL E  36
HIS E  45
1.61A
EDO  E 205 (-4.2A)
EPE  E 202 (-3.1A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA E  50
VAL E  49
VAL E  96
HIS E  45
1.67A
EPE  E 202 (-3.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA C  89
VAL C  30
VAL C 121
HIS C  91
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL E 147
TYR E 113
VAL E  36
HIS E 119
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  96
HIS A  45
1.70A
APR  A 201 (-3.4A)
APR  A 201 (-3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  96
HIS B  45
1.69A
APR  B 201 (-3.5A)
APR  B 201 (-3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL D 147
TYR D 113
VAL D  36
HIS D 119
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL D 147
TYR D 113
VAL D  36
HIS D 119
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL E 147
TYR E 113
VAL E  36
HIS E 119
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA D  50
VAL D  49
VAL D  96
HIS D  45
1.69A
APR  D 201 (-3.6A)
APR  D 201 (-3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA C  50
VAL C  49
VAL C  96
HIS C  45
1.68A
APR  C 201 (-3.6A)
APR  C 201 (-3.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL E 147
TYR E 113
VAL E  36
HIS E 119
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL D 147
TYR D 113
VAL D  36
HIS D 119
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA E  50
VAL E  49
VAL E  96
HIS E  45
1.68A
APR  E 201 (-3.4A)
APR  E 201 (-3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  96
HIS A  45
1.68A
MES  A 201 ( 3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA C  50
VAL C  49
VAL C  96
HIS C  45
1.54A
MES  C 201 ( 3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  95
HIS A  45
1.69A
MES  A 201 ( 3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ILE C  23
ALA C  50
VAL C  36
HIS C  45
1.62A
EDO  C 206 (-4.1A)
MES  C 201 ( 3.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA C  50
VAL C  49
VAL C  96
HIS C  45
1.66A
MES  C 201 ( 3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  95
HIS B  45
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ILE A  23
ALA A  50
VAL A  36
HIS A  45
1.62A
None
MES  A 201 ( 3.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA A  50
VAL A  49
VAL A  35
HIS A  94
1.76A
MES  A 201 ( 3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  96
HIS B  45
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA C  50
VAL C  49
VAL C  35
HIS C  94
1.77A
MES  C 201 ( 3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.50A
None
None
None
EDO  B 203 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ILE B  23
ALA B  50
VAL B  36
HIS B  45
1.61A
EDO  B 202 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  35
HIS B  94
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.42A
None
None
None
EDO  B 203 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  95
HIS B  45
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA C  50
VAL C  49
VAL C  95
HIS C  45
1.69A
MES  C 201 ( 3.8A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL B 147
TYR B 113
VAL B  36
HIS B 119
1.50A
None
None
None
EDO  B 203 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL A 147
TYR A 113
VAL A  36
HIS A 119
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
VAL C 147
TYR C 113
VAL C  36
HIS C 119
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 6
ALA B  50
VAL B  49
VAL B  35
HIS B  94
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bqy MAIN PROTEASE
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.07A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ILE A 696
ALA A 702
VAL A 700
VAL A 764
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
NSP7
(SARS-CoV-2)		4 / 6
ALA A 443
VAL A 410
TYR A 546
HIS C  36
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ALA A 581
THR A 582
TYR A 483
VAL A 588
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ALA A 771
VAL A 776
VAL A 764
HIS A 613
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ALA A 585
THR A 586
VAL A 587
VAL A 605
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ILE A 715
ALA A  46
THR A 710
VAL A  42
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ALA A 878
THR A 870
TYR A 867
VAL A 820
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ALA A 702
THR A 701
VAL A 704
VAL A 476
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
NSP7
(SARS-CoV-2)		4 / 6
ALA A 443
VAL A 410
TYR A 546
HIS C  36
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP8
(SARS-CoV-2)		4 / 6
ILE B 185
ALA B 188
THR B 187
VAL B 130
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ILE A 757
THR A 586
VAL A 588
VAL A 763
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7btf NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		4 / 6
ILE A 213
ALA A 255
THR A 257
VAL A 297
1.04A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ALA A 702
THR A 701
VAL A 704
VAL A 476
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ALA A 702
THR A 701
VAL A 704
VAL A 476
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ALA A 702
THR A 701
VAL A 704
VAL A 476
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
THR A 344
VAL A 359
VAL A 535
HIS A 355
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
NSP7
(SARS-CoV-2)		4 / 6
ALA A 443
VAL A 410
TYR A 546
HIS C  36
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ILE A 757
THR A 586
VAL A 588
VAL A 763
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ILE A 757
THR A 586
VAL A 588
VAL A 764
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
NSP7
(SARS-CoV-2)		4 / 6
ALA A 443
VAL A 410
TYR A 546
HIS C  36
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ALA A 878
THR A 870
TYR A 867
VAL A 820
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ILE A 696
ALA A 702
VAL A 700
VAL A 764
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ALA A 702
THR A 701
VAL A 704
VAL A 476
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
NSP7
(SARS-CoV-2)		4 / 6
ALA A 443
VAL A 410
TYR A 546
HIS C  36
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP8
(SARS-CoV-2)		4 / 6
ILE B 185
ALA B 188
THR B 187
VAL B 130
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv1 NSP12
(SARS-CoV-2)		4 / 6
ALA A 878
THR A 870
TYR A 867
VAL A 820
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ALA A 878
THR A 870
TYR A 867
VAL A 820
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ILE A 757
THR A 586
VAL A 588
VAL A 763
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
THR A 344
VAL A 359
VAL A 535
HIS A 355
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ALA A 702
THR A 701
VAL A 704
VAL A 476
1.19A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ILE A 696
ALA A 702
VAL A 700
VAL A 764
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP8
(SARS-CoV-2)		4 / 6
ILE B 185
ALA B 188
THR B 187
VAL B 130
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
NSP7
(SARS-CoV-2)		4 / 6
ALA A 443
VAL A 410
TYR A 546
HIS C  36
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_A_ILEA602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
NSP7
(SARS-CoV-2)		4 / 6
ALA A 443
VAL A 410
TYR A 546
HIS C  36
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ALA A 878
THR A 870
TYR A 867
VAL A 820
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ALA A 379
VAL A 330
VAL A 398
HIS A 381
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
NSP7
(SARS-CoV-2)		4 / 6
ALA A 443
VAL A 410
TYR A 546
HIS C  36
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ILE A 715
ALA A  46
THR A 710
VAL A  42
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_D_ILED601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ALA A 702
THR A 701
VAL A 704
VAL A 476
1.27A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECL_D_ILED602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ILE A 757
THR A 586
VAL A 588
VAL A 764
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECK_A_ILEA601_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)		7bv2 NSP12
(SARS-CoV-2)		4 / 6
ALA A 699
THR A 701
VAL A 704
VAL A 476
1.69A
None